Cargando…

Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation

Detalles Bibliográficos
Autores principales: Pico de Coaña, Yago, Wolodarski, Maria, Gentilcore, Giusy, Yoshimoto, Yuya, Poschke, Isabel, Hansson, Johan, Masucci, Giuseppe V, Kiessling, Rolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315271/
http://dx.doi.org/10.1186/1479-5876-13-S1-O7
_version_ 1782355449164595200
author Pico de Coaña, Yago
Wolodarski, Maria
Gentilcore, Giusy
Yoshimoto, Yuya
Poschke, Isabel
Hansson, Johan
Masucci, Giuseppe V
Kiessling, Rolf
author_facet Pico de Coaña, Yago
Wolodarski, Maria
Gentilcore, Giusy
Yoshimoto, Yuya
Poschke, Isabel
Hansson, Johan
Masucci, Giuseppe V
Kiessling, Rolf
author_sort Pico de Coaña, Yago
collection PubMed
description
format Online
Article
Text
id pubmed-4315271
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43152712015-02-12 Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation Pico de Coaña, Yago Wolodarski, Maria Gentilcore, Giusy Yoshimoto, Yuya Poschke, Isabel Hansson, Johan Masucci, Giuseppe V Kiessling, Rolf J Transl Med Oral Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315271/ http://dx.doi.org/10.1186/1479-5876-13-S1-O7 Text en Copyright © 2015 Pico de et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Oral Presentation
Pico de Coaña, Yago
Wolodarski, Maria
Gentilcore, Giusy
Yoshimoto, Yuya
Poschke, Isabel
Hansson, Johan
Masucci, Giuseppe V
Kiessling, Rolf
Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
title Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
title_full Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
title_fullStr Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
title_full_unstemmed Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
title_short Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation
title_sort ipilimumab treatment decreases circulating tregs and grmdsc while enhancing cd4+ t cell activation
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315271/
http://dx.doi.org/10.1186/1479-5876-13-S1-O7
work_keys_str_mv AT picodecoanayago ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT wolodarskimaria ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT gentilcoregiusy ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT yoshimotoyuya ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT poschkeisabel ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT hanssonjohan ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT masuccigiuseppev ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation
AT kiesslingrolf ipilimumabtreatmentdecreasescirculatingtregsandgrmdscwhileenhancingcd4tcellactivation